Optimal Allocation of Societal HIV Prevention Resources to Reduce HIV Incidence in the United States
Bibliographic Data
Objectives. To optimize combined public and private spending on HIV prevention to achieve maximum reductions in incidence. Methods. We used a national HIV model to estimate new infections from 2018 to 2027 in the United States. We estimated current spending on HIV screening, interventions that move persons with diagnosed HIV along the HIV care continuum, pre-exposure prophylaxis, and syringe services programs. We compared the current funding allocation with 2 optimal scenarios: (1) a limited-reach scenario with expanded efforts to serve eligible persons and (2) an ideal, unlimited-reach scenario in which all eligible persons could be served. Results. A continuation of the current allocation projects 331 000 new HIV cases over the next 10 years. The limited-reach scenario reduces that number by 69%, and the unlimited reach scenario by 94%. The most efficient funding allocations resulted in prompt diagnosis and sustained viral suppression through improved screening of high-risk persons and treatment adherence support for those infected. Conclusions. Optimal allocations of public and private funds for HIV prevention can achieve substantial reductions in new infections. Achieving reductions of more than 90% under current funding will require that virtually all infected receive sustained treatment
Business · Environmental health · Family medicine · Human immunodeficiency virus (HIV) · Incidence (geometry) · Psychological intervention · Public health · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Nursing · Sex work and related issues
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas — United States, 2013
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013
Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana
Ending the HIV Epidemic
Estimation of HIV Incidence in the United States
Viral suppression and HIV transmission in serodiscordant male couples
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER)
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
Distributive Syringe Sharing and Use of Syringe Services Programs (SSPs) Among Persons Who Inject Drugs
Syringe Exchange in the United States
| Unique citing works | 1 |
|---|---|
| Citations per year | 0,5 |
| Citation span | 2024 - 2024 (1) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 1 |